Physician profile
Robert Yarber
NPI 1447261268
$6,806.30
in general payments reported to CMS, 2019-2025
20 companies · $1,505 in 2025
The $1,505 reported for 2025 was more than what 86% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $114 · 2021: $220 · 2022: $720 · 2023: $1,363 · 2024: $2,443 · 2025: $1,505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,258 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,257.75 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $4,662.94 | 2022-2025 | Inspire |
| Genzyme Corporation | $446.71 | 2020-2025 | |
| Aerin Medical INC. | $360.83 | 2021-2025 | |
| Acclarent, INC | $329.25 | 2019-2024 | Trudi Nav Cable |
| Intersect Ent, INC. | $260.67 | 2019-2021 | |
| Stryker Corporation | $179.44 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $148.84 | 2023-2025 | Dupixent |
| Cumberland Pharmaceuticals, INC. | $112.82 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $52.99 | 2025 | |
| Neurent Medical Limited | $46.69 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Glaxosmithkline, LLC. | $32.67 | 2025 | Nucala |
| Olympus America INC. | $30.29 | 2020-2022 | |
| Amgen INC. | $20.86 | 2024 | Tavneos |
| Acera Surgical, INC. | $20.59 | 2023 | Restrata Wound Matrix |
| Itamar Medical INC | $19.87 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $18.83 | 2019 | |
| Medtronic, INC. | $17.67 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $17.26 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $15.19 | 2023 | |
| Arbor Pharmaceuticals, INC. | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Yarber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.